NDAOPHTHALMICSUSPENSION/DROPS
Approved
Apr 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Mechanism of Action
Carbonic Anhydrase Inhibitors
Pharmacologic Class:
Carbonic Anhydrase Inhibitor
Clinical Trials (5)
Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
Started Feb 2018
637 enrolled
GlaucomaOpen Angle or Ocular Hypertension
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
Started Sep 2017
1 enrolled
Glaucoma
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Started Jun 2014
327 enrolled
GlaucomaOcular Hypertension
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil
Started Mar 2012
Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
Started Jan 2012
258 enrolled
GlaucomaOpen Angle or Ocular Hypertension